Total Payments
$490.27
2024 Payments
$178.40
Companies
5
Transactions
16
Medicare Patients
1,575
Medicare Billing
$167,920
Payment Breakdown by Category
Food & Beverage$490.27 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $490.27 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $366.03 | 10 | $0 (2024) |
| GENZYME CORPORATION | $50.00 | 3 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $33.76 | 1 | $0 (2022) |
| Covidien LP | $23.27 | 1 | $0 (2020) |
| Daiichi Sankyo Inc. | $17.21 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178.40 | 4 | ABBVIE INC. ($161.19) |
| 2023 | $105.27 | 6 | ABBVIE INC. ($55.27) |
| 2022 | $168.91 | 4 | ABBVIE INC. ($135.15) |
| 2021 | $14.42 | 1 | AbbVie Inc. ($14.42) |
| 2020 | $23.27 | 1 | Covidien LP ($23.27) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/02/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Immunology | ||||||
| 06/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Immunology | ||||||
| 06/03/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 03/17/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: IMMUNOLOGY | ||||||
| 03/10/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $96.31 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/29/2020 | Covidien LP | Barrx (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Ablation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 303 | 374 | $114,020 | $31,875 |
| 2022 | 11 | 448 | 560 | $186,005 | $50,602 |
| 2021 | 11 | 455 | 531 | $183,490 | $49,188 |
| 2020 | 8 | 369 | 421 | $141,729 | $36,255 |
Total Patients
1,575
Total Services
1,886
Medicare Billing
$167,920
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 142 | $19,880 | $8,448 | 42.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 53 | $12,826 | $4,961 | 38.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 31 | 31 | $17,825 | $3,975 | 22.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $12,650 | $2,779 | 22.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 14 | 14 | $13,272 | $2,774 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 32 | $5,920 | $2,741 | 46.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 23 | $12,857 | $1,927 | 15.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 15 | 15 | $8,385 | $1,326 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,300 | $1,049 | 31.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $4,730 | $974.09 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $2,375 | $921.27 | 38.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 91 | 186 | $26,040 | $10,020 | 38.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 62 | $15,004 | $6,365 | 42.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 39 | 39 | $22,425 | $4,777 | 21.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 21 | 21 | $10,500 | $3,769 | 35.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 19 | 19 | $18,012 | $3,663 | 20.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $15,525 | $3,427 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 48 | $6,000 | $3,014 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 31 | $5,735 | $2,568 | 44.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $17,329 | $2,509 | 14.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 12 | 12 | $11,376 | $2,383 | 21.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 13 | 13 | $6,500 | $2,344 | 36.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 26 | 26 | $14,534 | $1,832 | 12.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $7,740 | $1,571 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,125 | $1,548 | 37.5% |
About Dr. Douglas Klions, M.D
Dr. Douglas Klions, M.D is a Gastroenterology healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518951854.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Klions, M.D has received a total of $490.27 in payments from pharmaceutical and medical device companies, with $178.40 received in 2024. These payments were reported across 16 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($490.27).
As a Medicare-enrolled provider, Klions has provided services to 1,575 Medicare beneficiaries, totaling 1,886 services with total Medicare billing of $167,920. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Latrobe, PA
- Active Since 09/01/2005
- Last Updated 01/29/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1518951854
Products in Payments
- RINVOQ (Biological) $282.46
- DUPIXENT (Biological) $83.76
- SKYRIZI (Biological) $46.69
- Barrx (Device) $23.27
- HUMIRA (Biological) $22.46
- INJECTAFER (Drug) $17.21
- DALVANCE (Drug) $14.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.